These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37871298)

  • 61. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs.
    Feng W; Liu J; Ao H; Yue S; Peng C
    Theranostics; 2020; 10(24):11278-11301. PubMed ID: 33042283
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Developing a metagenomic view of xenobiotic metabolism.
    Haiser HJ; Turnbaugh PJ
    Pharmacol Res; 2013 Mar; 69(1):21-31. PubMed ID: 22902524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
    Taguer M; Maurice CF
    Clin Pharmacol Ther; 2016 Jun; 99(6):588-99. PubMed ID: 26950037
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biotransformation and Gut Microbiota-Mediated Bioactivity of Flavonols.
    Wang M; Lu Y; Wu Q; Chen G; Zhao H; Ho CT; Li S
    J Agric Food Chem; 2023 Jun; 71(22):8317-8331. PubMed ID: 37249228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gut microbiota promote biotransformation and bioaccumulation of arsenic in tilapia.
    Song D; Chen L; Zhu S; Zhang L
    Environ Pollut; 2022 Jul; 305():119321. PubMed ID: 35439597
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interaction of Intestinal Microbiota with Medications.
    Liu M; Xu J; Jin Q; Li Y
    Curr Drug Metab; 2023; 24(8):554-567. PubMed ID: 37073652
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polyphenol Utilization Proteins in the Human Gut Microbiome.
    Zheng B; He Y; Zhang P; Huo YX; Yin Y
    Appl Environ Microbiol; 2022 Feb; 88(3):e0185121. PubMed ID: 34851722
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PASS-based prediction of metabolites detection in biological systems.
    Rudik AV; Dmitriev AV; Lagunin AA; Filimonov DA; Poroikov VV
    SAR QSAR Environ Res; 2019 Oct; 30(10):751-758. PubMed ID: 31542944
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The biotransformation of
    Tang C; Fu Q; Chen X; Hu Y; Renaud H; Ma C; Rao T; Chen Y; Tan Z; Klaassen CD; Shi S; Guo Y
    Xenobiotica; 2020 Sep; 50(9):1011-1022. PubMed ID: 31858877
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of gut microbiota in drug response.
    Wilson ID; Nicholson JK
    Curr Pharm Des; 2009; 15(13):1519-23. PubMed ID: 19442168
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Guo YP; Shao L; Chen MY; Qiao RF; Zhang W; Yuan JB; Huang WH
    J Agric Food Chem; 2020 Jun; 68(25):6835-6844. PubMed ID: 32449854
    [No Abstract]   [Full Text] [Related]  

  • 75. Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice.
    Chi L; Xue J; Tu P; Lai Y; Ru H; Lu K
    Arch Toxicol; 2019 Jan; 93(1):25-35. PubMed ID: 30357543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel Techniques and Models for Studying the Role of the Gut Microbiota in Drug Metabolism.
    Tan J; Fu B; Zhao X; Ye L
    Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):131-147. PubMed ID: 38123834
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systematic prediction of health-relevant human-microbial co-metabolism through a computational framework.
    Heinken A; Thiele I
    Gut Microbes; 2015; 6(2):120-30. PubMed ID: 25901891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Consensus Prediction of Human Gut Microbiota-Mediated Metabolism Susceptibility for Small Molecules by Machine Learning, Structural Alerts, and Dietary Compounds-Based Average Similarity Methods.
    Zheng S; Wang L; Xiong J; Liang G; Xu Y; Lin F
    J Chem Inf Model; 2022 Feb; 62(4):1078-1099. PubMed ID: 35156807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations.
    Bustion AE; Nayak RR; Agrawal A; Turnbaugh PJ; Pollard KS
    Elife; 2023 Jun; 12():. PubMed ID: 37306300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.